Pelorus Venture Capital specializes in providing funding for seed and early stage companies. With a focus on supporting the growth and development of emerging businesses, Pelorus Venture Capital plays a crucial role in helping entrepreneurs bring their innovative ideas to market. Through strategic investments and guidance, Pelorus Venture Capital aims to fuel the success of startups and contribute to the expansion of the entrepreneurial ecosystem.
Sequence Bio is a biotechnology company focused on enhancing drug discovery and development by leveraging the genetic diversity found in isolated populations, particularly in Newfoundland. The company aims to improve the treatment of complex and inherited diseases through its genome therapy platform, which involves collecting DNA and health information from these unique populations. By understanding the genetic factors that contribute to disease, Sequence Bio seeks to identify better drug targets and create more effective medicines, ultimately addressing the high failure rate of drug candidates and expediting the delivery of much-needed therapies to patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.